BACE1 and amyloidosis: Instead of glucose, galactose was conjugated to the nanoparticle surface to allow efficient penetration of the BBB via glycemia-controlled GLUT1–mediated transport so that the encapsulated siRNA can be delivered to the brain to decrease BACE1 expression and reduce amyloid plaque levels.